Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension
P. Stiefel et al., Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension, METABOLISM, 50(2), 2001, pp. 157-160
The aim of this study was to analyze the influence of the apolipoprotein E
(apoE) gene polymorphism on insulin resistance and plasma lipid composition
of essential hypertensive patients. A secondary objective was to analyze i
f differences regarding plasma lipids had an effect on the erythrocyte memb
rane lipid composition and the activity of the erythrocyte membrane sodium-
lithium countertransport. We studied 128 untreated nondiabetic essential hy
pertensive patients enrolled from our outpatient clinic. We considered as h
yperinsulinemic all subjects having more than 80 mU/L of plasma insulin 120
minutes after a 75-g oral glucose intake. The number of hyperinsulinemic s
ubjects among carriers of the epsilon4 allele was higher that in epsilon4 n
oncarrier subjects (13 of 19 v 45 of 109, P < .05; odds ratio [OR], 3.08; c
onfidence interval [Cl], 0.99-10.57). Plasma insulin at baseline and plasma
insulin and glucose at 120 minutes after overload was higher in carriers o
f the <epsilon>4 allele (respectively, 17.5 +/- 6.9 v 12.4 +/- 4.9 mU/L, P
< .01; 111.9 +/- 39.9 v 88.7 +/- 48.2, P < .05; and 143.8 +/- 29.3 v 121.2
+/- 30.8 mg/dL, P < .005). Subjects with the e4 allele had a plasma lipid p
rofile more atherogenic than those without this allele. This profile was ma
inly characterized by higher levels of low-density lipoprotein (LDL) choles
terol (150.1 +/- 31.2 v 133.0 +/- 34.3 mg/dL, P < .05) and very-low-density
lipoprotein (VLDL) triglycerides (134.7 +/- 85.5 v 99.2 +/- 68.8 mg/dL. P
< .05) and by lower levels of high-density lipoprotein (HDL) cholesterol (4
1.8 +/- 10.7 v 50.0 +/- 14.7 mg/dL, P < .05). There were no differences bet
ween groups regarding erythrocyte membrane cholesterol or phospholipids com
position and sodium-lithium countertransport (SLC) activity, Copyright (C)
2001 by W.B. Saunders Company.